Zobrazeno 1 - 10
of 262
pro vyhledávání: '"R. van Buuren"'
Using InSAR settlement data in a levee strengthening project for building settlement risk assessment
Publikováno v:
Proceedings of the International Association of Hydrological Sciences, Vol 382, Pp 697-702 (2020)
For the levee strengthening project Krachtige IJsseldijken Krimpenerwaard (KIJK) a study has been done to examine all buildings along 10 km of levee. These buildings are an important factor in the design stage, because of its sensitivity to deforma
Externí odkaz:
https://doaj.org/article/ead6a1174f70454f8f219de57d1cb5f5
Publikováno v:
Proceedings of the International Association of Hydrological Sciences, Vol 382, Pp 57-62 (2020)
For the dike strengthening project Krachtige IJsseldijken Krimpenerwaard (KIJK) a study has been undertaken to optimize the amount of land subsidence. Based on archive information originally a subsidence rate of 11 mm yr−1 is used in the design
Externí odkaz:
https://doaj.org/article/75038e6a0c234332ab291bc692894e0f
Autor:
Lowiek M. Hubers, Alex R. Schuurman, Jorie Buijs, Nahid Mostafavi, Marco J. Bruno, Roel C.H. Vermeulen, Anke Huss, Henk R. van Buuren, Ulrich Beuers
Publikováno v:
JHEP Reports, Vol 3, Iss 6, Pp 100385- (2021)
Background & Aims: Immunoglobulin G4-related disease (IgG4-RD) of the biliary tract and pancreas is a fibroinflammatory disease of unknown origin with striking male predominance. We aimed to investigate whether blue-collar work and occupational conta
Externí odkaz:
https://doaj.org/article/5d67c5c28e984c7a868ebbaea753ddfc
Autor:
R. van Buuren
Publikováno v:
Onderneming en Financiering. 30:49-63
The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathy
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
Background: After 5 years since the registration of rifaximin-α as a secondary prophylaxis for overt hepatic encephalopathy (HE) in the Netherlands, we aimed to evaluate the use of hospital resources and safety of rifaximin-α treatment in a real-wo
Externí odkaz:
https://doaj.org/article/dfe7a1deee9c4770a1f96e6c8e29357e
Publikováno v:
Annals of Hepatology, Vol 13, Iss 4, Pp 316-326 (2014)
Primary biliary cirrhosis (PBC) is a slowly progressive autoimmune liver disease that may ultimately result in liver failure and premature death. Predicting outcome is of key importance in clinical management and an essential requirement for patients
Externí odkaz:
https://doaj.org/article/9e06d5d522134baca319fca9ff0dafbf
Using InSAR settlement data in a levee strengthening project for building settlement risk assessment
Autor:
Jacco K. Haasnoot, Rob R. van Buuren, Marco Weijland, Hans J. W. van Zanten, Michel de Koning
Publikováno v:
Proceedings of the International Association of Hydrological Sciences, Vol 382, Pp 697-702 (2020)
For the levee strengthening project Krachtige IJsseldijken Krimpenerwaard (KIJK) a study has been done to examine all buildings along 10 km of levee. These buildings are an important factor in the design stage, because of its sensitivity to deformati
Publikováno v:
Proceedings of the International Association of Hydrological Sciences, Vol 382, Pp 57-62 (2020)
For the dike strengthening project Krachtige IJsseldijken Krimpenerwaard (KIJK) a study has been undertaken to optimize the amount of land subsidence. Based on archive information originally a subsidence rate of 11 mm yr−1 is used in the design
Autor:
Saskia Riemslag Baas-van der Ree, Robert A. de Man, Nicole S. Erler, Pim Aarts, Patty L.M. Lakenman, Rosalie C. Oey, Monique C. van Kemenade, Herold J. Metselaar, Henk R. van Buuren
Publikováno v:
Clinical Nutrition ESPEN, 36, 36-44. Elsevier Ltd.
Summary Background & aims Sarcopenia is prevalent in patients with liver cirrhosis and is negatively associated with clinical outcomes. In a population screened for liver transplantation we aimed to assess the prevalence of abnormal nutritional statu
Autor:
Gideon M. Hirschfield, Maryam Ebadi, Xavier Verhelst, Federica Malinverno, Nora Cazzagon, Pierre Belnou, Christophe Corpechot, Falk Rauchfuss, Olivier Boillot, Raoul Poupon, Jérôme Dumortier, Palak J. Trivedi, Maria Francesca Donato, Sascha Chopra, Dennis Eurich, Francesco Paolo Russo, Martina Sterneck, Aldo J. Montano-Loza, Maren H. Harms, Fabrice Carrat, Philipp A. Reuken, Christoph Schramm, Alexie Bosch, Albert Parés, Patrick McDowell, Davide Roccarina, Andrew Mason, Jorn C Goet, Bettina E. Hansen, Emiliano Giostra, Anna Reig, Annarosa Floreani, Dietmar Jacob, Douglas Thorburn, Olivier Chazouillères, Tony Bruns, Alessio Gerussi, Henk R. van Buuren, Filomena Conti, Frederik Nevens
Publikováno v:
Journal of Hepatology, 73(3), 559-565. Elsevier
Journal of Hepatology
Journal of Hepatology, Elsevier, 2020, 73, pp.559-565. ⟨10.1016/j.jhep.2020.03.043⟩
Journal of Hepatology
Journal of Hepatology, Elsevier, 2020, 73, pp.559-565. ⟨10.1016/j.jhep.2020.03.043⟩
Background & Aims: Recurrence of primary biliary cholangitis (PBC) after liver transplantation (LT) is frequent and can impair graft and patient survival. Ursodeoxycholic acid (UDCA) is the current standard therapy for PBC. We investigated the effect